Sieper J - Search Results

1

Braun J, Sieper J. Braun J, et al. Among authors: sieper j. Lancet. 2007 Apr 21;369(9570):1379-1390. doi: 10.1016/S0140-6736(07)60635-7. Lancet. 2007. PMID: 17448825 Review.

2

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

Brandt J, Haibel H, Reddig J, Sieper J, Braun J. Brandt J, et al. Among authors: sieper j. J Rheumatol. 2002 Jan;29(1):118-22. J Rheumatol. 2002. PMID: 11824947 Clinical Trial.

3

Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.

Sieper J, Rudwaleit M, Braun J, van der Heijde D. Sieper J, et al. Arthritis Rheum. 2002 Feb;46(2):319-27. doi: 10.1002/art.504. Arthritis Rheum. 2002. PMID: 11840434 Free article. Review. No abstract available.

4

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Braun J, Sieper J. Braun J, et al. Among authors: sieper j. Arthritis Res. 2002;4(5):307-21. doi: 10.1186/ar592. Epub 2002 Aug 6. Arthritis Res. 2002. PMID: 12223105 Free PMC article. Review.

5

Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.

Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J. Zou J, et al. Among authors: sieper j. Arthritis Rheum. 2003 Mar;48(3):780-90. doi: 10.1002/art.10847. Arthritis Rheum. 2003. PMID: 12632433 Free article.

6

Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases.

Braun J, Sieper J. Braun J, et al. Among authors: sieper j. Expert Opin Biol Ther. 2003 Feb;3(1):141-68. doi: 10.1517/14712598.3.1.141. Expert Opin Biol Ther. 2003. PMID: 12718738 Review.

7

Biologic therapies in the spondyloarthritis: new opportunities, new challenges.

Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J. Braun J, et al. Among authors: sieper j. Curr Opin Rheumatol. 2003 Jul;15(4):394-407. doi: 10.1097/00002281-200307000-00005. Curr Opin Rheumatol. 2003. PMID: 12819466 Review.

8

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J. Brandt J, et al. Among authors: sieper j. J Rheumatol. 2004 Mar;31(3):531-8. J Rheumatol. 2004. PMID: 14994401 Clinical Trial.

9

An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis.

Appel H, Neure L, Kuhne M, Braun J, Rudwaleit M, Sieper J. Appel H, et al. Among authors: sieper j. Clin Rheumatol. 2004 Oct;23(5):435-40. doi: 10.1007/s10067-004-0916-5. Epub 2004 Jul 28. Clin Rheumatol. 2004. PMID: 15459815

10

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. van der Heijde D, et al. Among authors: sieper j. Arthritis Rheum. 2005 Feb;52(2):582-91. doi: 10.1002/art.20852. Arthritis Rheum. 2005. PMID: 15692973 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

643 results

Search Page

Filters